Diabetes mellitus and other associated comorbidities as a poor prognostic factor in patients with COVID-19

Authors

Keywords:

COVID-19, SAR-CoV-2, diabetes mellitus, high blood pressure, obesity, cardiovascular diseases

Abstract

The current pandemic, generated by the new coronavirus called severe acute respiratory syndrome, coronavirus 2, causes the disease known as COVID-19, which can present severe forms with high mortality; patients with diabetes mellitus and associated comorbidities have a worse prognosis. A review of the existing literature was carried out in databases such as MEDLINE, LILACS, SciELO, LATINDEX, MEDIGRAPHY, MEDSCAPE, Science Direct Elsevier, PubMed and World Health Organization/Pan American Health Organization, bulletins as well as the INFOMED Portal, with the aim of evaluating some aspects related to the increase in mortality in this particular group. A total of 83 articles were reviewed, 24 were selected. Diabetes mellitus and related comorbidities constitute a poor prognosis in the evolution of patients with COVID-19.

 

Downloads

Download data is not yet available.

Author Biographies

Marcel Deniel Mendieta Pedroso, Hospital Leopoldito Martínez Facultad de Ciencias Médicas de Mayabeque. San José de las Lajas,

Doctor en Ciencias Médicas. Especialista de I y II grado en Medicina Interna. Especialista de I y II grado en Medicina General Integral. Máster en Urgencias Médicas. Investigador Agregado. Profesor Titular. Hospital Leopoldito Martínez Facultad de Ciencias Médicas de Mayabeque. San José de las Lajas,

Efraín Boyeros Fernández, Policlínico Universitario Luis Li Tregent. Güines,

Especialista de I y II grado en Medicina Interna. Profesor Auxiliar y Master en Ciencias en Medicina Natural y Tradicional. Policlínico Universitario Luis Li Tregent. Facultad de Ciencias Médicas Mayabeque. Güines,

References

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [Internet]. 2020[citado 6 jul 2020];17(5):259-60 (2020).Disponible: https://doi.org/10.1038/s41569-020-0360-5

Emami A, Javanmardi F. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med[ Internet]. 2020 [citado 6 jul 2020]; 8(1): [aprox. 12 p.]. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/

Serra Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay [Internet]. 2020 [citado 6 Jul 2020]; 10(2): [aprox. 10 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/846

Fadini GP, Morieri ML, Longato E, Avogaro A .Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrino lInvest [Internet]. 2020 [citado 6 jul 2020]; 43:867–9. Disponible: https://doi.org/10.1007/s40618-020-01236-2

Longo M, Caruso P, Maiorino MI. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies. Cardiovasc Diabetol [Internet]. 2020[citado 6 Jul 2020];19: [aprox. 11 p.]. https://doi.org/10.1186/s12933-020-01090-9

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID ‐19. Diabetes MetabSyndr. [Internet]. 2020 [citado: 6 jul 2020]; 14(4): [aprox. 10 p.]. Disponible: https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3319

Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev[Internet]. 2020 [citado: 6 jul 2020];36(7):e332113321. Disponible https://link.springer.com/article/10.1007/s40618-020-01236-2

Huang I, Lim MA. PranataR. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes &Metabolic Syndrome: ClinicalResearch&Reviews [Internet]. 2020 [citado 6 Jul 2020];14(4):395-403. Disponible: https://www.sciencedirect.com/science/article/pii/S1871402120300837

Tay MZ, Poh CM, Rénia L. The trinity of COVID-19: immunity, inflammation and intervention. NatRevImmunol[Internet]. 2020[citado 31 Jul 2020];20(6):363-74. Disponible en https://doi.org/10.1038/s41577-020-0311-8

Serra Valdés MA. COVID-19. De la patogenia a la elevada mortalidad en el adulto mayor y con comorbilidades. Revista Habanera de Ciencias Médicas [Internet]. 2020 [citado 31 Jul 2020];19(3):[aprox. 6 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3379

Samada Suárez M, Hernández Perera JC , Piñeiro Pérez D. ¿El SARS-C0V-2 puede ser diabetógeno? Boletín Científico del Cimeq [Internet]. 2020 Jul [citado 6 jul 2020]; 1(16): [aprox. 8 p.]. Disponible https://instituciones.sld.cu/bolcimeq/2020/07/06/el-sars-c0v-2-puede-ser-diabetogeno/#more-425

Aguilera Batista O, Bruzón Laguna E de la C. Recomendaciones prácticas para el manejo de los pacientes diabéticos con la COVID-19. Boletín Científico del Cimeq [Internet]. 2020 [citado 4 Ago 2020];1(12):4-5. Disponible en: https://instituciones.sld.cu/bolcimeq/2020/06/08/recomendaciones-practicas-para-el-manejo-de-los-pacientes-diabeticos-con-la-covid-19/

Mejía F, Medina C, Cornejo E, Morello E, Vásquez S, Alave J et al. Clinical features and prognostic factors related to mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru [Internet].2020 Jun[citado 4 Ago 2020]. Disponible; https://preprints.scielo.org/index.php/scielo/preprint/view/858/

Preciado-Ortiz ME , Sánchez-Reyes K , Álvarez-Zavala M , González-Hernández LA , Ramos-Solano M , Andrade-Villanueva J. Obesidad e infecciones REVISTA MÉDICA MD [Internet]. 2018 [citado 4 Ago 2020];9(4):[aprox. 8 p.]. Disponible: https://www.medigraphic.com/pdfs/revmed/md-2018/md184n.pdf

Stefan N, Birkenfeld AL, Schulze MB. Obesity and impaired metabolic health in patients with COVID-19. NatRevEndocrinol [Internet]. 2020 [citado 4 Ago 2020]; 16:341-2. Disponible: https://doi.org/10.1038/s41574-020-0364-6

Luis Miguel Miranda-Garduño* y Alfredo Reza-Albarrán. Obesidad, inflamación y diabetes. GacMédMéx[Internet].2008 [citado 4 Ago 2020];144(1): [aprox. 12 p.]. Disponible :https://www.medigraphic.com/pdfs/gaceta/gm-2008/gm081h.pdf

Dietz W, Santos‐Burgoa C. Obesity and its Implications for COVID‐19 Mortality. Obesity [Internet]. 2020 [citado 6 Jul 2020); 28(6): [aprox. 13 p.]. Disponible: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22818

Bell Castillo Josefa, George CarriónWilberto, GarcíaCéspedesMaría Eugenia, Delgado Bell Evelyn, George Bell María de Jesús. Identification of metabolic syndrome in patients with diabetes mellitus and hypertension.MEDISAN [Internet]. 2017 Oct [citado 4 Ago 2020];21(10):3038-45. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192017001000007&lng=es

Chen Q, Zheng Z, Zhang C. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection[Internet]. 2020[citado 6 Ago 2020];48(4):543-51. Disponible: https://doi.org/10.1007/s15010-020-01432-5

Valdés Ramos E, Bencosme Rodríguez N. Frecuencia de la hipertensión arterial y su relación con algunas variables clínicas en pacientes con diabetes mellitus tipo 2. Rev Cubana Endocrinol [Internet]. 2009 Dic [citado 4 Ago 2020]; 20(): 77-88. Disponible en: http://scielo.sld.cu/scielo.php?

Giralt-Herrera A, Rojas-Velázquez JM, Leiva-Enríquez J. Relación entre COVID-19 e Hipertensión Arterial. Revhabanciencméd [Internet]. 2020 [citado 4 Ago 2020]; 19(2):e_3246. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3246

Hipertensión Arterial .La Hipertensión Arterial podría elevar el riesgo de muerte por COVID-19 [citado 4 Ago 2020]. Disponible: https://www.drugs.com/news/blood-pressure-might-raise-covid-19-death-risk-

Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. NatRevNephrol[Internet]. 2020 [citado 4 Ago 2020];16(6):311-3 https://doi.org/10.1038/s41581-020-0280-y

Bender-del-Busto J, León-Castellón R, Mendieta-Pedroso M. Enfermedad cerebrovascular y COVID-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 13 Ago 2020];10(2):[aprox. 7 p.]. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/802

Downloads

Published

2023-12-30

How to Cite

1.
Rodríguez Carrasco BB, Mendieta Pedroso MD, Boyeros Fernández E. Diabetes mellitus and other associated comorbidities as a poor prognostic factor in patients with COVID-19. Medimay [Internet]. 2023 Dec. 30 [cited 2024 Oct. 16];30(4):512-9. Available from: https://medimay.sld.cu/index.php/rcmh/article/view/1754

Issue

Vol. 30 No. 4 (2023)

Section

CURRENT ISSUE

License

Medimay protects copyright from the very first moment the submission is made, but upon publication it assumes a Creative Commons 4.0 (cc-by-nc) license, which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build from the material) as long as exclusive mention is made of the publication in the journal as a primary source, prohibiting its commercialization. The author always retains his/her right.

Most read articles by the same author(s)

1 2 > >>